If you are a bit overweight or obese, you have some good news. The FDA has changed it’s “deny every weight loss drug policy” and is moving in the right direction.
Ironically, the FDA did not have a single Bariatrician or weight loss doctor on their panel that reviews weight loss medications until recently. As soon as they have a bariatric doctor on the panel, coincidentally or otherwise, they have two new weight loss medications – Qsymia which is a combination of Phentermine and Topiramate and Belviq (Lorcaserin).
Here is the information on Qsymia™ (Qsymia is the trade mark of Vivus, Inc.)
W8MD Medical Weight Loss Centers Of America’s unique insurance physician weight loss clinics in greater Philadelphia, NJ and NYC have extensive experience in both the brand name Qsymia™ or the generic combination of Phentermine along with Topiramate (generic version is similar to the brand name although not identical as there no generic equivalent available) for successful weight loss along with Very Low Calorie or Low Calorie Diets, Behavior Modification, and other evidence based measures.
Cost of Qsymia Brand Name Weight Loss Medication
Approximately $150.00 to $160.00 per month at about $3.00 a pill.
Cost of the generic combination of Phentermine and Topiramate at W8MD Medical Weight Loss Centers
Varies from $45.00 USD biweekly for both Phentermine and Topirmate at a dollar a pill for cost saving of 40-50 percent with the generic combination.
W8MD Medical Weight Loss Centers That Accept Most Insurances For Weight Loss Visits.
W8MD medical weight loss program at Vida Sleep Center of Dr. Felix Roque’s office at 543, 45th Street, Union City, New Jersey. 543 45th St, Union City, NJ 07087. Phone (201)766-6469. This W8MD medical weight loss center in New Jersey bills out of network for insurance.
Related weight loss articless
- Contrave (Bupropion and Naltrexone) – new weight loss medication
- Saxenda – FDA approved in December 2014.
- Phentermine and Topiramate (Qsymia)
- Lorcaserin (Belviq) – weight loss medication FDA approved in June of 2012.
- Phentermine (Adipex)
- Topiramate (Topamax)